Biogen
BIIB
BIIB
1,012 hedge funds and large institutions have $59.3B invested in Biogen in 2016 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 338 increasing their positions, 399 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% less call options, than puts
Call options by funds: $1.49B | Put options by funds: $1.59B
15% less repeat investments, than reductions
Existing positions increased: 338 | Existing positions reduced: 399
Holders
1,012
Holding in Top 10
57
Calls
$1.49B
Puts
$1.59B
Top Buyers
| 1 | +$389M | |
| 2 | +$191M | |
| 3 | +$162M | |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$125M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$122M |
Top Sellers
| 1 | -$540M | |
| 2 | -$321M | |
| 3 | -$320M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$172M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$121M |